Join the Oncology Voice Network. Join for Free
Career Currency: The Key to Your Success
network building career currency MSL networking internal relationships job search strategies

Career Currency: The Key to Your Success


Share This Article


Summary

In this week’s episode, Rachel Couchenour, Vice President Global Medical Affairs at Travere Therapeutics, discusses the importance of building your internal and external network.

Learn more about…

👉 What is career currency
👉 Why it is so important for MSLs to build a strong internal network
👉 What opportunities might develop through internal networking
👉 How does an MSL go about developing internal relationships
👉 How can MSLs influence future promotions or job search efforts

Click for Source
network building, career currency, MSL networking, internal relationships, job search strategies

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Combatting the “Summer Slow Down"​ – MSL Job Search Tips for Slower Months
Partner Avatar Tom Caravela

Combatting the “Summer Slow Down"​ – MSL Job Search Tips for Slower Months

Podcast
Job Search Jumpstart: 8 Simple Steps to Get More Interviews
Partner Avatar MSL Talk: Tom Caravela

Job Search Jumpstart: 8 Simple Steps to Get More Interviews

Podcast
How I landed my first MSL role... what works, what doesn't, and what you need to know
Partner Avatar MSL Talk: Tom Caravela, Julie Chen

How I landed my first MSL role... what works, what doesn't, and what you need to know

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
OVN Avatar R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Explore OVN